Biohaven announces preliminary 3q2021 net product revenue for nurtec odt, the first and only migraine medication for both acute and preventive treatment

New haven, conn., oct. 5, 2021 /prnewswire/ -- biohaven pharmaceutical holding company ltd.

BHVN Ratings Summary

BHVN Quant Ranking